EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer
Synergy · 2015
DOI: 10.1016/j.synres.2015.05.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synergy, 2015. Verfasst von Elvis Boamah und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Center Teaching Research Excellence Seed Grant Award from Chicago State University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Center Teaching Research Excellence Seed Grant Award from Chicago State University
Zitieren
APA
Boamah, E., Ibrahim, Q., Kwinji, L., Patel, R., Ajayi, D., & Danquah, M. (2015). EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer. Synergy. https://doi.org/10.1016/j.synres.2015.05.001
Vancouver
Boamah E, Ibrahim Q, Kwinji L, Patel R, Ajayi D, Danquah M. EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer. Synergy. 2015. doi:10.1016/j.synres.2015.05.001
BibTeX
@article{Boamah2015,
author = {Boamah, Elvis and Ibrahim, Qudus and Kwinji, Lordcarse and Patel, Ruchi and Ajayi, Dolapo and Danquah, Michael},
title = {EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer},
journal = {Synergy},
year = {2015},
doi = {10.1016/j.synres.2015.05.001}
}
EUVIMED